Literature DB >> 16641301

Identification and characterization of novel adeno-associated virus isolates in ATCC virus stocks.

Michael Schmidt1, Emmanuelle Grot, Peter Cervenka, Sandra Wainer, Charles Buck, John A Chiorini.   

Abstract

Adeno-associated viruses (AAVs) depend on a helper virus for efficient replication. To identify novel AAV isolates, we screened a diverse set of virus isolates for the presence of AAV DNA. AAVs found in 10 simian adenovirus isolates showed greater than 96% homology to AAV1 and AAV6 but had distinct biological properties. Two representatives of this group, AAV(VR-195) and AAV(VR-355), were studied in more detail. While the novel AAVs had high sequence homologies and required sialic acid for cell binding and transduction, differences were observed in lectin competition, resulting in distinct tropisms in human cancer cell lines.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16641301      PMCID： PMC1472088          DOI： 10.1128/JVI.80.10.5082-5085.2006

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  16 in total

1.  Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid.

Authors:  Richard H Smith; Sandra A Afione; Robert M Kotin
Journal:  Biotechniques       Date:  2002-07       Impact factor: 1.993

2.  ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES.

Authors:  R W ATCHISON; B C CASTO; W M HAMMON
Journal:  Science       Date:  1965-08-13       Impact factor: 47.728

3.  Cloning and characterization of a bovine adeno-associated virus.

Authors:  Michael Schmidt; Hisako Katano; Ioannis Bossis; John A Chiorini
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity.

Authors:  N Kaludov; K E Brown; R W Walters; J Zabner; J A Chiorini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics.

Authors:  M D Hoggan; N R Blacklow; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1966-06       Impact factor: 11.205

6.  Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer.

Authors:  R W Walters; S M Yi; S Keshavjee; K E Brown; M J Welsh; J A Chiorini; J Zabner
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

7.  Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

Authors:  E A Rutledge; C L Halbert; D W Russell
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Identification of a heparin-binding motif on adeno-associated virus type 2 capsids.

Authors:  A Kern; K Schmidt; C Leder; O J Müller; C E Wobus; K Bettinger; C W Von der Lieth; J A King; J A Kleinschmidt
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Identification of adeno-associated virus contamination in cell and virus stocks by PCR.

Authors:  Hisako Katano; Sandra Afione; Michael Schmidt; John A Chiorini
Journal:  Biotechniques       Date:  2004-04       Impact factor: 1.993

10.  Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding.

Authors:  Shaun R Opie; Kenneth H Warrington; Mavis Agbandje-McKenna; Sergei Zolotukhin; Nicholas Muzyczka
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103
View more
  23 in total

1.  Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6.

Authors:  Zhijian Wu; Edward Miller; Mavis Agbandje-McKenna; Richard Jude Samulski
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Proteolytic mapping of the adeno-associated virus capsid.

Authors:  Kim Van Vliet; Veronique Blouin; Mavis Agbandje-McKenna; Richard O Snyder
Journal:  Mol Ther       Date:  2006-09-27       Impact factor: 11.454

3.  Capsid antibodies to different adeno-associated virus serotypes bind common regions.

Authors:  Brittney L Gurda; Michael A DiMattia; Edward B Miller; Antonette Bennett; Robert McKenna; Wendy S Weichert; Christian D Nelson; Wei-jun Chen; Nicholas Muzyczka; Norman H Olson; Robert S Sinkovits; John A Chiorini; Sergei Zolotutkhin; Olga G Kozyreva; R Jude Samulski; Timothy S Baker; Colin R Parrish; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

4.  Adeno-associated virus enhances wild-type and oncolytic adenovirus spread.

Authors:  Eduardo Laborda; Cristina Puig-Saus; Manel Cascalló; Miguel Chillón; Ramon Alemany
Journal:  Hum Gene Ther Methods       Date:  2013-10-08       Impact factor: 2.396

Review 5.  Targeted gene therapy for the treatment of heart failure.

Authors:  Kleopatra Rapti; Antoine H Chaanine; Roger J Hajjar
Journal:  Can J Cardiol       Date:  2011 May-Jun       Impact factor: 5.223

Review 6.  Large animal models of neurological disorders for gene therapy.

Authors:  Christine Gagliardi; Bruce A Bunnell
Journal:  ILAR J       Date:  2009

7.  Reducing the risk of adeno-associated virus (AAV) vector mobilization with AAV type 5 vectors.

Authors:  F Curtis Hewitt; Chengwen Li; Steven J Gray; Shelley Cockrell; Michael Washburn; R Jude Samulski
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  Epidermal growth factor receptor is a co-receptor for adeno-associated virus serotype 6.

Authors:  Melodie L Weller; Panomwat Amornphimoltham; Michael Schmidt; Paul A Wilson; J Silvio Gutkind; John A Chiorini
Journal:  Nat Med       Date:  2010-05-09       Impact factor: 53.440

9.  Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942).

Authors:  Michael Schmidt; Lakshmanan Govindasamy; Sandra Afione; Nick Kaludov; Mavis Agbandje-McKenna; John A Chiorini
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

10.  Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints.

Authors:  L H Vandenberghe; E Breous; H-J Nam; G Gao; R Xiao; A Sandhu; J Johnston; Z Debyser; M Agbandje-McKenna; J M Wilson
Journal:  Gene Ther       Date:  2009-12       Impact factor: 5.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.